MUMBAI, India, Sept. 28 -- Intellectual Property India has published a patent application (202637085104 A) filed by Shanghai Institute Of Materia Medica, Chinese; and Beijing Tiantan Hospital, Capital Medical University on July 11, 2026, for Use Of 1-(3-Aminopropyl) Substituted Cyclic Amine Compound.
Inventors include Liu, Hong; Shi, Fudong; Wang, Jiang; and Shi, Kaibin.
The application for the patent was published on September 25, 2026, under issue no. 39/2026.
Abstract: The present invention relates to pharmaceutical use of a 1-(3-aminopropyl) substituted cyclic amine compound. Specifically, the present invention relates to use of a 1- (3-aminopropyl) substituted cyclic amine compound represented by general formula (I) or a pharmaceutically acceptable salt thereof, a solvate thereof, an optically pure isomer thereof, a stereoisomer thereof, or a mixture thereof in the preparation of a drug for treating and/or preventing multiple sclerosis and related diseases thereof.
Disclaimer: Curated by HT Syndication.
